vps-39 Antibody

What is VPS39 and what cellular functions does it regulate?

VPS39, also known as VAM6, TLP, or hVam6p, is an 886 amino acid protein containing one CNH domain and one CHCR repeat. It functions as a component of the HOPS complex, which is crucial for lysosomal-endosomal membrane fusion. VPS39 promotes lysosome clustering and fusion in vivo and plays important roles in:

• Regulating autophagy pathways through control of autophagic flux

• Modulating TGF-beta signaling by coupling the TGF-beta receptor complex to the Smad pathway

• Controlling ciliogenesis through autophagy-dependent mechanisms

• Contributing to glucose metabolism in muscle tissue

VPS39 is widely expressed in mammalian tissues, with highest levels detected in heart, skeletal muscle, kidney, pancreas, brain, placenta, and spleen .

How does VPS39 function within the HOPS complex structure?

Within the HOPS complex, VPS39 serves as one of the six subunits (alongside Vps11, Vps18, Vps16, Vps33, and Vps41) that collectively mediate membrane tethering and fusion events. Structural studies have revealed:

• VPS39 is located at the periphery of the complex

• It binds to membrane-anchored small GTPases (Rab7-like Ypt7 in yeast)

• The N-terminal region (residues 1-700) contains flexible elements with incompletely resolved structure

• The C-terminal portion (residues 701-1045) interacts with the core subunits of the complex

• AlphaFold modeling has been employed to predict structural features of VPS39

What optimization strategies are recommended for immunoprecipitation with VPS39 antibodies?

For successful immunoprecipitation (IP) experiments targeting VPS39:

• Optimal antibody dilutions typically range between 1:200-1:1000 for IP applications

• Mouse brain tissue has been validated as an effective source material, using approximately 4000μg of lysate per experiment

• The expected molecular weight of VPS39 is approximately 102 kDa when detected by Western blot

• Rat liver tissue lysate is recommended as a positive control for antibody validation

• When immunoprecipitating VPS39, include appropriate negative controls (IgG from the same species) to confirm specificity

A combination of IP followed by mass spectrometry can be particularly valuable for identifying novel VPS39 interaction partners involved in specific cellular processes.

How can researchers effectively study VPS39's role in autophagy regulation?

To investigate VPS39's functions in autophagy:

• Knockdown and overexpression approaches:

  • siRNA-mediated silencing of VPS39 in cell models blocks autophagy, as evidenced by increased LC3II and p62 protein levels

  • Overexpression of 3XFlag-hVPS39 enhances autophagic flux when combined with Bafilomycin A1 treatment

• Autophagy flux analysis:

  • Monitor LC3II and p62 levels by Western blotting in the presence and absence of lysosomal inhibitors

  • Compare autophagic flux between control and VPS39-manipulated samples to quantify differences

• Microscopy-based assays:

  • Immunofluorescence to track colocalization of VPS39 with autophagy markers

  • Live-cell imaging with fluorescently tagged autophagy proteins to observe dynamic changes

VPS39 deficiency has been shown to impair autophagy in multiple cell types, with downstream effects on ciliogenesis and muscle stem cell differentiation .

What considerations are important when selecting VPS39 antibodies for different applications?

When selecting VPS39 antibodies:

Additional considerations:

• Verify antibody cross-reactivity with species of interest (human VPS39 antibodies may not recognize all orthologs)

• Consider antibody clonality (polyclonal antibodies provide better sensitivity but potentially lower specificity)

• For critical experiments, validate findings with multiple antibodies targeting different VPS39 epitopes

How can researchers investigate VPS39's dual roles in HOPS complex function versus its independent activities?

VPS39 exhibits both HOPS-dependent and independent functions that require different experimental approaches:

For HOPS-dependent functions:

• Structure-guided mutagenesis targeting the RING finger domains that mediate complex assembly can selectively disrupt HOPS interactions while preserving independent functions

• AlphaFold predictions coupled with experimental validation can identify key interfaces between VPS39 and other HOPS components

• Selective knockdown of other HOPS components (e.g., Vps11) followed by assessment of VPS39-dependent processes can distinguish between complex-dependent and independent activities

For independent functions:

• Domain-specific mutations that preserve HOPS complex formation but alter other interactions

• Proximity labeling approaches (BioID, APEX) to identify non-HOPS interaction partners

• Subcellular fractionation to isolate VPS39 populations not associated with the HOPS complex

Research has shown that VPS39 plays HOPS-independent roles in TGF-beta signaling and potentially in muscle metabolism regulation .

What methodological approaches reveal VPS39's role in metabolic disorders like type 2 diabetes?

Recent research has identified VPS39 deficiency as a contributor to type 2 diabetes pathophysiology:

• Expression profiling:

  • VPS39 is downregulated in myoblasts and myotubes from individuals with type 2 diabetes

  • qRT-PCR and Western blotting can quantify these differences in patient-derived samples

• Functional metabolism assays:

  • Glucose uptake measurements in Vps39+/- mouse models show reduced uptake in muscle tissue

  • Insulin signaling pathway analysis reveals VPS39's impact on metabolic regulation

• Multi-omics approach:

  • Transcriptomics to identify dysregulated gene sets (cell cycle, muscle structure, apoptosis)

  • Epigenomic profiling to detect alterations in DNA methylation patterns

  • Proteomics to assess changes in autophagy regulatory proteins

• Myoblast differentiation assays:

  • Microscopic assessment of differentiation markers

  • Quantification of fusion index and myotube formation

  • Analysis of myogenic regulatory factor expression

These approaches have revealed that VPS39 deficiency impairs myoblast differentiation and glucose uptake through mechanisms involving autophagy and epigenetic reprogramming .

How do experimental models of VPS39 disruption inform our understanding of its developmental roles?

VPS39 is essential for early mammalian development, with knockout mice dying at or before embryonic day 6.5 . Several experimental approaches provide insights into its developmental functions:

• Conditional knockout models:

  • Tissue-specific deletion using Cre-lox systems

  • Temporal control with inducible promoters

  • Assessment of tissue-specific developmental phenotypes

• Stem cell differentiation models:

  • VPS39 knockdown in muscle stem cells reveals its role in myogenic differentiation

  • iPSC models can evaluate effects on multiple differentiation pathways

• Embryoid body formation:

  • Three-dimensional culture systems to model early development

  • Assessment of VPS39's role in tissue organization and specification

• CRISPR-Cas9 genome editing:

  • Generation of precise mutations mimicking disease-associated variants

  • Knockin reporters to track VPS39 expression during development

• Developmental signaling pathway analysis:

  • Evaluation of TGF-beta, WNT, and other key developmental pathways

  • Protein-protein interaction studies with developmental regulators

These approaches collectively demonstrate VPS39's critical roles in cellular differentiation pathways and suggest potential developmental origins of metabolic disorders associated with VPS39 dysfunction .

What imaging techniques best capture VPS39's role in membrane trafficking and fusion events?

To visualize VPS39's functions in membrane dynamics:

• Advanced fluorescence microscopy:

  • Super-resolution techniques (STED, PALM, STORM) to visualize subcellular localization at nanoscale resolution

  • Multi-color confocal microscopy to track colocalization with organelle markers

  • FRET/FLIM to assess protein-protein interactions in situ

• Live-cell imaging approaches:

  • Spinning disk confocal microscopy for rapid acquisition of dynamic events

  • Photoactivatable fluorescent proteins to track organelle dynamics

  • Correlative light-electron microscopy (CLEM) to combine functional and ultrastructural data

• Electron microscopy techniques:

  • Immunogold labeling to localize VPS39 at the ultrastructural level

  • Tomography to create 3D reconstructions of membrane contact sites

  • Cryo-EM for high-resolution structural analysis of membrane complexes

• Functional imaging approaches:

  • pH-sensitive probes to monitor lysosomal fusion events

  • Cargo trafficking assays with fluorescently labeled markers

  • FRAP (Fluorescence Recovery After Photobleaching) to measure protein dynamics

These imaging approaches have revealed VPS39's localization patterns and dynamic interactions during processes like lysosomal fusion and autophagosome maturation .

What are common technical challenges when working with VPS39 antibodies and how can they be addressed?

Researchers frequently encounter several challenges when using VPS39 antibodies:

• Specificity issues:

  • Problem: Cross-reactivity with related proteins

  • Solution: Validate with peptide competition assays; confirm results with multiple antibodies targeting different epitopes

• Detection sensitivity:

  • Problem: Low endogenous expression in some cell types

  • Solution: Enrich target protein via immunoprecipitation before immunoblotting; use signal amplification methods

• Background signal:

  • Problem: Non-specific binding in immunofluorescence applications

  • Solution: Optimize blocking conditions (BSA vs. serum); include additional washing steps; test alternative fixation methods

• Epitope masking:

  • Problem: Protein-protein interactions concealing antibody binding sites

  • Solution: Test multiple fixation/extraction protocols; consider native vs. denaturing conditions

• Validation in knockout systems:

  • Problem: Confirming antibody specificity definitively

  • Solution: Generate CRISPR knockout controls; use siRNA knockdown with appropriate controls

Each application may require specific optimization strategies to maximize signal-to-noise ratio and ensure reliable detection of VPS39.

How can researchers distinguish between direct and indirect effects when studying VPS39 function?

Differentiating direct from indirect effects of VPS39 manipulation requires multiple complementary approaches:

• Acute vs. chronic interventions:

  • Rapid depletion systems (e.g., auxin-inducible degron tags)

  • Comparison with long-term knockdown/knockout phenotypes

  • Time-course experiments to establish sequence of events

• Rescue experiments:

  • Structure-function analysis with domain-specific mutants

  • Complementation with orthologs from other species

  • Expression of interaction-deficient variants

• Direct binding assays:

  • In vitro reconstitution with purified components

  • Surface plasmon resonance or isothermal titration calorimetry

  • Yeast two-hybrid or mammalian two-hybrid systems

• Proximity labeling approaches:

  • BioID or APEX2 fusions to identify proteins in close proximity

  • Comparison of proximal proteomes under different conditions

  • Validation of direct interactions with traditional biochemical methods

These strategies help establish causality and identify the primary molecular mechanisms through which VPS39 influences cellular processes like autophagy regulation and ciliogenesis .